Klaus Aktories – författare

Wer mit "Aktories" lernt, versteht

Das Standardwerk der Pharmakologie und Toxikologie in �berarbeiteter 13. Auflage: das gesamte Wissen auf �ber 1.000 Seiten. Bew�hrt als erstklassiges Lehrbuch f�r Medizin- und Pharmaziestudierende, begehrt als Nachschlagewerk f�r Medizinier*innen und Pharmakolog*innen.

Das gesamte Wissen der Pharmakologie und Toxikologie wird Ihnen hier verst�ndlich und anschaulich erkl�rt und bringt Ihnen Sichherheit beim Lernen:

Arzneimittelwirkungen im Gesamtzusammenhang begreifen: Wirkmechanismen und pathophysiologische Bez�ge in jedem Kapitel Zusammenh�nge verstehen: Ausf�hrliches Kapitel zur allgemeinen Pharmakologie und Toxikologie erleichtert Ihnen das Verst�ndnis der speziellen pharmakologischen Zusammenh�nge Praktische Relevanz: Empfehlungen zu Therapie und Dosierungen finden Sie in farbig hervorgehobenen K�sten

Neu in der 13. Auflage:

Hoch aktuelle Darstellung der Biologika (= das Gebiet der Pharmakologie, das am schnellsten w�chst): signifikante Neuentwicklungen f�r die Tumortherapie, der Therapie rheumatischer Erkrankungen und anderer Autoimmunerkrankungen, der Therapie allergischer Erkrankungen und der Therapie der Psoriasis (Schuppenflechte) Bemerkenswerte Erkenntnisse bei der Einf�hrung der SGLT-2-Inhibitoren (Sodium-Glucose-Like-Transporter 2) in der Diabetes-Typ2-Therapie� Darstellung der vielf�ltigen Zusammenh�nge von molekular-pharmakologischen Wirkungen der Arzneimittel und ihrer therapeutischen Anwendung (inklusive der mRNA-Technologie) Neue Arzneimittelentwicklungen Erg�nzung der IMPP-Arzneistoffliste (Markierung im Flie�text + eigenes Register)

This is a survey of well characterized and recently discovered bacterial protein toxins. Leading investigators of the respective toxins review the various molecular mechanisms of action, ranging from toxin-induced ADP-ribosylation up to membrane perforation by pore-forming toxins. Thy also describe the consequences on host physiology before focusing on potential applications as cell biological and pharmacological tools for research and medical applications. Detailed descriptions of the methodology include the engineering and use of modified and chimeric toxins for better performance. A solid introduction to toxin structure and functions, as well as a valuable source of methodology for researchers in molecular biology, pharmacology and experimental medicine.

With contributions by numerous experts

This volume brings together contributions from experts in the field of Pasteurella research. Its covers areas such as comparative genomics, pathogenic mechanisms, bacterial proteomics, as well as a detailed description and analysis of PMT and its interaction with host tissues, cells, immune system, and signalling pathways.

This volume brings together contributions from experts in the field of Pasteurella research. Its covers areas such as comparative genomics, pathogenic mechanisms, bacterial proteomics, as well as a detailed description and analysis of PMT and its interaction with host tissues, cells, immune system, and signalling pathways.

This volume brings together contributions from experts in the field of Pasteurella research. Its covers areas such as comparative genomics, pathogenic mechanisms, bacterial proteomics, as well as a detailed description and analysis of PMT and its interaction with host tissues, cells, immune system, and signalling pathways.

ADP-ribosylating toxins have been the focus of intensive research for more than 30 years. Researchers from diverse fields of science have taken an interest in these bacterial toxins; they are studied, for example, by microbiologists, biochemists, cell biologists, and pharmacologists. There are two principal reasons for the broad and still growing interest in ADP­ ribosylating toxins. First, insights into the structure and functions of the toxins might be the key to prevention and treatment of diseases caused by the toxin-producing infectious micro­ organisms. Second, the ADP-ribosylating toxins provide potent and often unique pharmacological tools for the study of the physiological functions of their target proteins. The latter is especially the case with cholera and pertussis toxins, which both modify the IX-subunits of heterotrimeric G-proteins involved in signal transduction pathways. These toxins have proved invaluable in extending our basic understanding of the regulation of hormone-controlled signal transduction. This volume provides a review and an update of recent studies on the basic properties of bacterial ADP-ribosylating tbxins and/or exoenzymes. Our current knowledge of the cel­ lular entry mechanisms of ADP-ribosylating toxins is reviewed by MADSHUS and STENMARK. WILSON and COLLIER then deal with recent insights into the enzyme mechanism and active site structure of diphtheria toxin and Pseudomonas aeruginosa exotoxin A, which modify elongation factor 2. Toxins which ADP-ribosylate heterotrimeric G-proteins involved in trans­ membrane signal transduction are the subject of the next two chapters.